Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double PHD fingers 1 (DPF1) is a neuron-enriched chromatin remodeling factor that mediates gene expression by recognizing specific histone modifications through its tandem PHD domains. It is part of the neuron-specific nBAF (SWI/SNF) complex, regulating neuronal differentiation and survival as neural progenitors exit mitosis. DPF1's activity is crucial for enabling transcriptional programs required for nervous system development, where its PHD fingers selectively bind acetylated and crotonylated histone H3 tails, thereby modulating chromatin structure and gene accessibility. Defects or dysregulation in DPF1 or related SWI/SNF components can result in neurodevelopmental syndromes and may have roles, as inferred from the PHD finger protein family, in cancer biology via epigenetic mechanisms[2][3][4][1].
Not applicable (no proven DPF1-targeting mechanism for existing drugs; in theory, inhibition or modulation would affect chromatin state and neuronal gene transcription)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double PHD fingers 1 (DPF1).